MediciNova Inc

Entity type image
Type: Company
Name: MediciNova Inc
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 MEDICINOVA INC For: May 13 Filed by: Johnson Kirk William

StreetInsider.com - Form 4 MEDICINOVA INC For: May 13 Filed by: Johnson Kirk William ... [Published Street Insider - May 16 2013]
Entities: MediciNova Inc
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 MEDICINOVA INC For: May 13 Filed by: Matsuda Kazuko

StreetInsider.com - Form 4 MEDICINOVA INC For: May 13 Filed by: Matsuda Kazuko ... [Published Street Insider - May 16 2013]
Entities: MediciNova Inc
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 MEDICINOVA INC For: May 13 Filed by: COFFEE MICHAEL DENIS

StreetInsider.com - Form 4 MEDICINOVA INC For: May 13 Filed by: COFFEE MICHAEL DENIS ... [Published Street Insider - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 MEDICINOVA INC For: May 13 Filed by: IWAKI YUICHI

StreetInsider.com - Form 4 MEDICINOVA INC For: May 13 Filed by: IWAKI YUICHI ... [Published Street Insider - May 16 2013]
Entities: MediciNova Inc, Iwaki
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Form 4 MEDICINOVA INC For: May 13 Filed by: Izumi Tatsuo

StreetInsider.com - Form 4 MEDICINOVA INC For: May 13 Filed by: Izumi Tatsuo ... [Published Street Insider - May 15 2013]
Entities: MediciNova Inc
First reported May 13 2013 - Updated May 14 2013 - 1 reports

Monday Sector Leaders: Biotechnology, Drugs

5 minutes ago, 3:01pm (ET) 05/13/2013 MarketNewsVideo.comIn trading on Monday, biotechnology shares were relative leaders, up on the day by about 1.7%. Leading the group were shares of Theravance (THRX), up about 15.8% and shares of Affymax (AFFY) up ... [Published Zecco - May 13 2013]
Entities: Biotechnology, Drugs, Stocks
First reported May 13 2013 - Updated May 13 2013 - 1 reports

Morning Market Movers

Today 10:02 AM ET (Benzinga)Pointer Telocation Ltd. (NASDAQ: PNTR) soared 59.38% to $4.59 after the company released its first quarter earnings results.Theragenics Corp. (NYSE: TGX) moved up 34.23% to $2.00 after the company announced receiving proposal ... [Published TD Ameritrade - May 13 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

MediciNova, Inc. Reports First Quarter 2013 Results

(GLOBE NEWSWIRE) -- MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced financial results for the first quarter ended ... [Published BioSpace - May 09 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

MediciNova Reports First Quarter 2013 Results

CONTACT: INVESTOR CONTACT:Mike CoffeeChief Business OfficerMediciNova, Inc.(858) 736-7180coffee@medicinova.com ... [Published Reuters - May 08 2013]
Entities: MediciNova Inc, Coffee
First reported May 08 2013 - Updated May 08 2013 - 1 reports

MediciNova Reports First Quarter 2013 Results

MediciNova, Inc. a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today announced financial results for the first quarter ended March 31, 2013 through ... [Published Zecco - May 08 2013]
First reported May 02 2013 - Updated May 02 2013 - 2 reports

5 Stocks Under $10 Set to Surge

Tickers in this article: AXDX BCRX DRWI NEPT PSDV RPTPMADISON, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow ... [Published Delco Times - May 02 2013]
First reported May 02 2013 - Updated May 02 2013 - 2 reports

Economic News Sends Market to the Downside

by Harry Boxer, www.TheTechTrader an AdviceTrade.com publication The stock market indices had a rough session today. Economic news pounded the markets, and the indices experienced a 5-wave decline. Only a last three-minute bounce off the lows kept them ... [Published Individual.com - May 02 2013]

Quotes

...path forward for the treatment of acute asthma," said Yuichi Iwaki, M D , Ph D, President and Chief Executive Officer of MediciNovaMediciNova Inc. "We believe we are well positioned to continue this progress in 2013 and the value that can provide for our shareholders."
...By tracking the size and price of each montha'a "s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin."
If you require information regarding today's European corporate news please refer to the RANsquawk "EU Equity Opening News' sheet or visit www.RANsquawk.com. "
...Yuichi Iwaki, President and CEO of MediciNova commented.$ "We look forward to initiating the NIDA-funded PhasePhase 2 outpatient clinical trial of MN-166 for the treatment of methamphetamine addiction with UCLA investigators."

More Content

All (37) | News (27) | Reports (2) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Top Insider Trades: A Big Purchase at Six Flags... [Published Minyanville - May 16 2013]
Top Insider Trades 5/15/13: SIX, VNTV, RP, OFIX [Published Seeking Alpha - May 16 2013]
Form 4 MEDICINOVA INC For: May 13 Filed by: COF... [Published Street Insider - May 16 2013]
Form 4 MEDICINOVA INC For: May 13 Filed by: Joh... [Published Street Insider - May 16 2013]
Form 4 MEDICINOVA INC For: May 13 Filed by: Mat... [Published Street Insider - May 16 2013]
Form 4 MEDICINOVA INC For: May 13 Filed by: IWA... [Published Street Insider - May 16 2013]
Form 4 MEDICINOVA INC For: May 13 Filed by: Izu... [Published Street Insider - May 15 2013]
Monday Sector Leaders: Biotechnology, Drugs [Published Zecco - May 13 2013]
Morning Market Movers [Published TD Ameritrade - May 13 2013]
MediciNova, Inc. Reports First Quarter 2013 Res... [Published BioSpace - May 09 2013]
MediciNova (MNOV) Releases Quarterly Earnings R... [Published American Banking News - Earnings - May 09 2013]
Medicinova Inc Lowers Consolidated Mid-year Out... [Published Reuters - May 09 2013]
MediciNova Reports First Quarter 2013 Results [Published GlobeNewswire: Acquisitions News - May 08 2013]
MediciNova Reports First Quarter 2013 Results [Published Reuters - May 08 2013]
MediciNova Reports First Quarter 2013 Results [Published Zecco - May 08 2013]
5 Stocks Under $10 Set to Surge [Published Delco Times - May 02 2013]
5 Stocks Under $10 Set to Surge [Published AdvisorSource.com - May 02 2013]
DTK, IWC, ARII, LINTB, AZC, MNOV Are Seasonally... [Published Individual.com - May 02 2013]
Economic News Sends Market to the Downside [Published Individual.com - May 02 2013]
Economic News Sends Market to the Downside [Published Zecco - May 02 2013]
Form 4 MEDICINOVA INC For: Jun 14 Filed by: Oka... [Published Street Insider - Apr 26 2013]
Form 4 MEDICINOVA INC For: Jun 14 Filed by: Joh... [Published Street Insider - Apr 26 2013]
Form 4 MEDICINOVA INC For: Jun 14 Filed by: COF... [Published Street Insider - Apr 26 2013]
Form 4 MEDICINOVA INC For: Jun 14 Filed by: IWA... [Published Street Insider - Apr 26 2013]
MediciNova Reports Fourth Quarter and Full Year... [Published GlobeNewswire: Acquisitions News - Mar 28 2013]
MediciNova Announces MN-166 (ibudilast) Opioid ... [Published GlobeNewswire: Acquisitions News - Mar 20 2013]
Secretive Dilution And A Possible Equity Financ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 27 2013]
Biotech Industry Soars in 2012 as FDA Drug Appr... [Published Marketwire - Breaking News Releases - Feb 27 2013]
4 Healthcare Stock Stories to Heal the Tuesday ... [Published Wall St. Cheat Sheet - Feb 26 2013]
US EQUITIES OPENING HEADLINES INCLUDING: JPMorg... [Published Proactiveinvestors United Kingdom RSS feed - Feb 26 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
4 Healthcare Stock Stories to Heal the Tuesday ... [Published Wall St. Cheat Sheet - Feb 26 2013]
AstraZeneca Group ( NYSE:AZN ): Closing price $44.92 On Tuesday, the firm announced high-level results from KODIAC-08, an open-label, randomised, 52-week long-term safety evaluation of naloxegol. UC was defined as the investigator’s choice of an existing ...
1

Press Releases

sort by: Date | Relevance
MediciNova Reports First Quarter 2013 Results [Published GlobeNewswire: Acquisitions News - May 08 2013]
MediciNova Reports Fourth Quarter and Full Year... [Published GlobeNewswire: Acquisitions News - Mar 28 2013]
MediciNova Announces MN-166 (ibudilast) Opioid ... [Published GlobeNewswire: Acquisitions News - Mar 20 2013]
Biotech Industry Soars in 2012 as FDA Drug Appr... [Published Marketwire - Breaking News Releases - Feb 27 2013]
FDA Grants Fast Track Designation for MediciNov... [Published GlobeNewswire: Acquisitions News - Feb 25 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.